Clinical Trials
- Orthopaedics, Muscle & Bone, Immune System
A Study To Evaluate The Efficacy And Safety Of Obinutuzumab In Patients With ISN/RPS 2003 Class III Or IV Lupus Nephritis (REGENCY)
- Ages18 years - 75 years
- GenderBoth
- Date09/14/2021
- Immune System
Efficacy and Safety of AMG 570 in Subjects With Active Systemic Lupus Erythematosus (SLE)
- Ages18 years - 75 years
- GenderBoth
- Date04/27/2021
- Orthopaedics, Muscle & Bone, Immune System
Nature of Anifrolumab Impact on Vaccine-Emergent Immunity in SLE (NAIVE)
- Ages18 years - 70 years
- GenderBoth
- Date10/08/2021
- Immune System
Yale Lupus and Connective Tissue Disease Bio-Repository / Yale Rheumatology Bio-Repository
- Ages18 years and older
- GenderBoth
- Date10/01/2016
- Arthritis
Yale Rheumatology Program Patient Registry and Bio-Repository
- Ages18 years - 99 years
- GenderBoth
- Date05/11/2020